TEAL NO UV SALMON 151C LM/UV MB2391B RED 186 CPSIA

RED DISP 57 PP GRAY 7544C W/UV DARK GRAY 7545C W/UV

UV PE SCOTTS GREEN UV PP SCOTTS GREEN INNER RED

RED PP UV BLUE SPLITTER PP JPMBQ UV BROWN

UV PE RED 11136 UV BRT RED V2-HC7762

SILCOGUM RED 67842 SF306188-01 EXP4110 UV-TRANS 10025344 WHITE W/UV

UV NEW GRAY PE 3 RED XTAL WARM GREY 11C FR/UV

Geon(TM) DB4979 Green 352 UV TRANS RED BASE ULTIMATE GRAY 966955 UV 248 ABS

UV TAN PP NYLON UV YELLOW 4 GEON L6256 RED 7425

Microsoft PowerPoint - Avient IR Presentation - June 2021 AVIENT CORPORATION J U N E 2 0 2 1 I N V E S T O R M E E T I N G S (NYSE: AVNT) DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. This innovation drives performance and is reflective of consistent, strategic investments in our portfolio…and people. 2020 Pro forma $991 $86 Sustainable Solutions 15 11% 6 Healthcare 28 22% 6 Composites 6 10% 3 Growth in Emerging Regions 44 30% 10 Other 53 10% 7 Sub-total $1,137 15% $118 FX Impact 25 - 2 Synergies - - 11 Incentives, Travel, Other Employee Costs - - (8) 2021 Actual $1,162 17% $123 Q1 2021 ORGANIC SALES AND OPERATING INCOME 18 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Sales Growth Rate Operating Income$ millions 19 Wire & Cable Transportation Industrial Healthcare Packaging Consumer Q1 2020PF Q1 2021 (2) Financial information is presented on a constant currency basis (1,2) (42% of total revenue) (58% of total revenue) Q1 END MARKET SALES PERFORMANCE +17% +14% +8% +10% +8% +22% +5% +24% Q 2 AN D FU LL Y EA R 2021 O U TLO O K A S O F A P R I L 3 0 , 2 0 2 1 W E B C A S T $69 $112 $0.42 $0.80 ORGANIC GROWTH PROJECTIONS – Q2 21 Sales Adjusted Operating Income $870 $1,100 + 26% + 62% + 90% (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition FULL YEAR GUIDANCE INCREASED 22 Sales Adj. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Other 10.4 18.2 16.0 15.5 15.3 11.3 11.0 29.7 26.5 23.5 18.2 13.4 11.9 11.9 11.7 10.5 10.4 10.3 10.1 9.7 7.7 6.5 en t Median: 11.7xMedian: 15.4x SUMMARY: WHY INVEST IN AVIENT?